COVID EHR COHORT at the University of Wisconsin
This cohort study will obtain electronic health record (EHR) data (limited data set) from 21 health systems affiliated with the Cancer Center Cessation Initiative (C3I) network or health systems with large numbers of COVID-19 patients to explore whether smoking status, cancer history, and other risk factors among patients diagnosed with COVID-19 are associated with mortality and/or COVID-19 disease severity/complications. Each site will provide data from their health system EHR on a regular basis that includes all patients identified as having COVID-19 at some point in the interval from February 1, 2020, through January 31, 2022.
Checked against the public recordLast updated Aug 31, 2022 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- University of Wisconsin, Madison
- Interventions being studied
- Not specified
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * COVID-19 ICD-10-CM diagnosis (U07.1 or J12.82) during a healthcare visit and/or * COVID-19 positive PCR test and/or * COVID-19 positive antigen test Exclusion Criteria: * N/A
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of Wisconsin School of Medicine and Public Health Center for Tobacco Research and InterventionMadison, Wisconsin
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 31, 2022. Always confirm current availability with the study team.